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Figure 1: Peripheral blood  
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Figure 2: Bone marrow aspirate (Perls' stain)  
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A 2-year-old boy was taken to the Accident and Emergency department with a persistent 
productive cough. Further assessment revealed a 6-month history of worsening pallor 
and lethargy. He had been born by emergency Caesarean section at 41 weeks gestation 
for fetal distress but had subsequently been healthy. Examination revealed no 
hepatosplenomegaly. He was small for age with height and weight on the 2nd and 0.4th 
centiles respectively. 
His full blood count showed a haemoglobin concentration (Hb) of 27 g/l, MCV 48 fl and 
MCH 13.5 pg, with reticulocytes 0.40 x 109/l. White cell count was 6.62 x 109/l, neutrophil 
count 2.23 x 109/l, platelet count 311 x 109/l and ferritin 262 µg/l. A peripheral blood film 
demonstrated dimorphic red cells with one population of normocytic, normochromic 
cells and a second population with marked poikilocytosis, target cells, irregular 
microcytes and fragmented red cells (left). Despite the dimorphic red cell morphology 
the clinical presentation was felt to be suggestive of hereditary pyropoikilocytosis. An 
eosin-5’- maleimide (EMA) binding test, however, was normal and a haemolysis screen 
was negative (bilirubin 6 µmol/l, lactate dehydrogenase 214 iu/l). A bone marrow 
aspirate showed normocellular erythropoiesis. A Perls’ stain (right) showed storage iron 
to be present; there were very occasional ring sideroblasts, constituting less than 1% of 
all sideroblasts.  
Both parents had normal Hb, red cell indices and EMA binding test. His mother’s blood 
film showed occasional elliptocytes but no other abnormalities. Further enquiry into the 
family history revealed a maternal male cousin with congenital sideroblastic anaemia. 
Subsequently targeted genetic analysis identified an unusual combination of 
abnormalities. The patient was hemizygous for a C to A nucleotide substitution in exon 7 
of ALAS2 (c.791 C>A), which, although not previously reported, was predicted to result in 
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the replacement of the amino acid serine with tyrosine at residue 264 (p.Ser264Tyr) and 
was therefore consistent with X-linked sideroblastic anaemia, inherited from his mother. 
In addition, he was heterozygous for SPTA1 (c.2608G>A; p.Val870Met) and SPTB 
(c.2519G>A; p.Arg840His) variants. Although not previously described, this digenic effect 
was felt to be potentially consistent with hereditary pyropoikilocytosis. The mother was a 
carrier of the SPTA1 genetic variant and had some elliptocytes, suggesting a 
spectrinopathy. 
At this stage, the predominant abnormality responsible for his phenotype was unclear. 
Due to the family history of congenital sideroblastic anaemia and the identification of a 
potential pathogenic ALAS2 variant a trial of pyridoxine therapy was commenced. A 
dramatic improvement in his Hb was seen, rising to 112 g/l within 3 months without 
further red cell transfusion. 
Despite the lack of overt sideroblastic change in his marrow aspirate, we postulate a 
primary diagnosis of pyridoxine-sensitive X-linked sideroblastic anaemia. Additional 
mutations associated with red cell membrane abnormalities may have contributed to the 
morphological abnormalities at presentation although this remains speculative. However, 
the absence of overt haemolysis and the dimorphic blood film were inconsistent with a 
significant pathological red cell membrane abnormality, such as hereditary 
pyropoikilocytosis. 
This case highlights the importance of correlation between genetic and phenotypic 
features in the diagnosis of congenital anaemia. It suggests that the absence of 
significant ring sideroblasts does not preclude a diagnosis of congenital sideroblastic 
anaemia. A thorough family history and appropriate genetic analysis was particularly 
important in this patient’s management. 
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A 2-year-old boy was taken to the Accident and Emergency department with a persistent 
productive cough. Further assessment revealed a 6-month history of worsening pallor 
and lethargy. He had been born by emergency Caesarean section at 41 weeks gestation 
for fetal distress but had subsequently been healthy. Examination revealed no 
hepatosplenomegaly. He was small for age with height and weight on the 2nd and 0.4th 
centiles respectively. 
His full blood count showed a haemoglobin concentration (Hb) of 27 g/l, MCV 48 fl and 
MCH 13.5 pg, with reticulocytes 0.40 × x 109/l. White cell count was 6.62 × x 109/l, 
neutrophil count 2.23 × x 109/l, platelet count 311 × x 109/l and ferritin 262 μgµg/l. A 
peripheral blood film demonstrated dimorphic red cells with one population of 
normocytic, normochromic cells and a second population with marked poikilocytosis, 
target cells, irregular microcytes and fragmented red cells (left). Despite the dimorphic 
red cell morphology the clinical presentation was felt to be suggestive of hereditary 
pyropoikilocytosis. An eosin-5’- maleimide (EMA) binding test, however, was normal and 
a haemolysis screen was negative (bilirubin 6 μmolµmol/l, lactate dehydrogenase 214 
iu/l). A bone marrow aspirate showed normocellular erythropoiesis. A Perls’ stain (right) 
showed storage iron to be present; there were very occasional ring sideroblasts, 
constituting less than 1% of all sideroblasts.  
Both parents had normal Hb, red cell indices and EMA binding test. His mother’s blood 
film showed occasional elliptocytes but no other abnormalities. Further enquiry into the 
family history revealed a maternal male cousin with congenital sideroblastic anaemia. 
Subsequently targeted genetic analysis was performed and identified an unusual 
combination of abnormalities. The patient was hemizygous for a C to A nucleotide 
substitution in exon 7 of the ALAS2 gene (c.791 C>A), which, although not previously 
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reported, was predicted to result in the replacement of the amino acid serine with 
tyrosine at residue 264 (p.Ser264Tyr) and was therefore consistent with X-linked 
sideroblastic anaemia, inherited from his mother. In addition, he was heterozygous for 
SPTA1 (c.2608G>A; p.Val870Met) and SPTB (c.2519G>A; p.Arg840His) variants. Although 
not previously described, this digenic effect was felt to be potentially consistent with 
hereditary pyropoikilocytosis. The mother was a carrier of the SPTA1 genetic variant and 
had some elliptocytes, suggesting a spectrinopathy. 
At this stage, the predominant abnormality responsible for his phenotype was unclear. 
Due to the family history of congenital sideroblastic anaemia and the identification of a 
potential pathogenic ALAS2 variant a trial of pyridoxine therapy was commenced. A 
dramatic improvement in his Hb was seen, rising to 112 g/l within 3 months without 
further red cell transfusion. 
Despite the lack of overt sideroblastic change in his marrow aspirate, we postulate a 
primary diagnosis of pyridoxine-sensitive X-linked sideroblastic anaemia. Additional 
mutations associated with red cell membrane abnormalities may have contributed to the 
morphological abnormalities at presentation although this remains speculative. However, 
the absence of overt haemolysis and the dimorphic blood film were inconsistent with a 
significant pathological red cell membrane abnormality, such as hereditary 
pyropoikilocytosis. 
This case highlights the importance of correlation between genetic and phenotypic 
features in the diagnosis of congenital anaemia. It suggests that the absence of 
significant ring sideroblasts does not preclude a diagnosis of congenital sideroblastic 
anaemia. A thorough family history and appropriate genetic analysis was particularly 
important in this patient’s management. 
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